News : pharmaceutical

Vibalogics Viral vector manufacturing facility
Vibalogics, a global contract development and manufacturing organization (CDMO), has announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical virotherapy manufacturing capacity. more...
Recombinant viral antigen collecting including coronavirus
Sino Biological has developed the world's largest recombinant viral antigen collection, ProVir™, which features an exclusive coronavirus catalog, a comprehensive collection of influenza antigens, and many other hard-to-find viral proteins such as Zika, RSV, Ebola, and Cytomegalovirus. more...
Recombinant Adeno-Associated Virus-Based Vectors
Biogen and Ginkgo are collaborating to improve the efficiency of AAV-producing plasmid vectors and cell lines for cell and gene therapy applications. Under the terms of the agreement, Biogen will receive access to Ginkgo’s proprietary cell programming platform and capabilities. more...
Virucidal Efficacy Testing
Eurofins BioPharma Product Testing Italy (Eurofins BTP Italy) has expanded its virucidal testing capacity with the opening of a dedicated laboratory. The laboratory will carry out testing and studies on disinfectant products to meet growing demand in the wake of the COVID-19 pandemic. more...
SARS-CoV-2 mutation analysis
baseclick has developed a new and more efficient process to determine predominant and minor mutations in the SARS-CoV-2 virus population which might eventually become new strains. more...